Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
47,284,486
-
Shares change
-
+4,604,432
-
Total reported value, excl. options
-
$148,479,513
-
Value change
-
+$13,347,500
-
Put/Call ratio
-
45.8%
-
Number of buys
-
54
-
Number of sells
-
-31
-
Price
-
$3.14
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2021
110 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q4 2021.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,284,486 shares
of 189,947,836 outstanding shares and own 24.9% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7,775,207 shares), MAVERICK CAPITAL LTD (5,593,389 shares), Bellevue Group AG (4,602,858 shares), PRIMECAP MANAGEMENT CO/CA/ (4,594,575 shares), M28 Capital Management LP (3,765,588 shares), BlackRock Inc. (2,894,363 shares), Kynam Capital Management, LP (1,494,594 shares), PLATINUM INVESTMENT MANAGEMENT LTD (1,336,105 shares), D. E. Shaw & Co., Inc. (1,110,289 shares), and MILLENNIUM MANAGEMENT LLC (1,092,098 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.